Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/43038
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Ordoñez, R. | |
dc.contributor.author | Henríquez-Hernández, L. A. | |
dc.contributor.author | Federico, M. | |
dc.contributor.author | Valenciano, A. | |
dc.contributor.author | Pinar, B. | |
dc.contributor.author | Lloret, M. | |
dc.contributor.author | Bordón, E. | |
dc.contributor.author | Rodríguez-Gallego, C. | |
dc.contributor.author | Lara, P. C. | |
dc.date.accessioned | 2018-11-21T12:12:37Z | - |
dc.date.available | 2018-11-21T12:12:37Z | - |
dc.date.issued | 2014 | |
dc.identifier.issn | 0179-7158 | |
dc.identifier.uri | http://hdl.handle.net/10553/43038 | - |
dc.description.abstract | Background and purpose. A close relationship exists between immune response and tumor behavior. This study aimed to explore the associations between radiation-induced apoptosis (RIA) in peripheral blood lymphocytes (PBL) and clinical pathological variables. Furthermore, it assessed the role of RIA as a prognostic factor for survival in cervical carcinoma patients.Patients and methods. Between February 1998 and October 2003, 58 consecutive patients with nonmetastatic, localized stage I-II cervical carcinoma who had been treated with radiotherapy (RT) +/- A chemotherapy were included in this study. Follow-up ended in January 2013. PBL subpopulations were isolated and irradiated with 0, 1, 2 and 8 Gy then incubated for 24, 48 and 72 h. Apoptosis was measured by flow cytometry and the beta value, a parameter defining RIA of lymphocytes, was calculated.Results. Mean follow-up duration was 111.92 +/- 40.31 months. Patients with lower CD8 T lymphocyte beta values were at a higher risk of local relapse: Exp(B) = 5.137, confidence interval (CI) 95 % = 1.044-25.268, p = 0.044. Similar results were observed for regional relapse: Exp(B) = 8.008, CI 95 % = 1.702-37.679, p = 0.008 and disease relapse: Exp(B) = 6.766, CI 95 % = 1.889-24.238, p = 0.003. In multivariate analysis, only the CD8 T lymphocyte beta values were found to be of prognostic significance for local disease-free survival (LDFS, p = 0.049), regional disease-free survival (RDFS, p = 0.002), metastasis-free survival (MFS, p = 0.042), disease-free survival (DFS, p = 0.001) and cause-specific survival (CSS p = 0.028).Conclusion. For the first time, RIA in CD8 T lymphocytes was demonstrated to be a predictive factor for survival in cervical carcinoma patients. | |
dc.publisher | 0179-7158 | |
dc.relation.ispartof | Strahlentherapie und Onkologie | |
dc.source | Strahlentherapie und Onkologie[ISSN 0179-7158],v. 190, p. 210-216 | |
dc.subject.other | Growth-Factor-Beta | |
dc.subject.other | Clinical Toxicity | |
dc.subject.other | Cancer Patients | |
dc.subject.other | Tgf-Beta | |
dc.subject.other | Radiation | |
dc.subject.other | Cells | |
dc.subject.other | Hypoxia | |
dc.subject.other | Tumor | |
dc.subject.other | Expression | |
dc.subject.other | Prediction | |
dc.title | Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients | |
dc.type | info:eu-repo/semantics/Article | es |
dc.type | Article | es |
dc.identifier.doi | 10.1007/s00066-013-0488-x | |
dc.identifier.scopus | 84893797725 | - |
dc.identifier.isi | 000330623000011 | |
dc.contributor.authorscopusid | 37261658100 | |
dc.contributor.authorscopusid | 15829708200 | |
dc.contributor.authorscopusid | 57201785606 | |
dc.contributor.authorscopusid | 55382811900 | |
dc.contributor.authorscopusid | 54904204300 | |
dc.contributor.authorscopusid | 6507421079 | |
dc.contributor.authorscopusid | 7003855087 | |
dc.contributor.authorscopusid | 24402677200 | |
dc.contributor.authorscopusid | 6602114379 | |
dc.contributor.authorscopusid | 7004374085 | |
dc.description.lastpage | 216 | |
dc.description.firstpage | 210 | |
dc.relation.volume | 190 | |
dc.type2 | Artículo | es |
dc.contributor.daisngid | 2115479 | |
dc.contributor.daisngid | 465624 | |
dc.contributor.daisngid | 29956480 | |
dc.contributor.daisngid | 13991533 | |
dc.contributor.daisngid | 1285881 | |
dc.contributor.daisngid | 802813 | |
dc.contributor.daisngid | 34952053 | |
dc.contributor.daisngid | 2045042 | |
dc.contributor.daisngid | 591076 | |
dc.contributor.wosstandard | WOS:Ordonez, R | |
dc.contributor.wosstandard | WOS:Henriquez-Hernandez, LA | |
dc.contributor.wosstandard | WOS:Federico, M | |
dc.contributor.wosstandard | WOS:Valenciano, A | |
dc.contributor.wosstandard | WOS:Pinar, B | |
dc.contributor.wosstandard | WOS:Lloret, M | |
dc.contributor.wosstandard | WOS:Bordon, E | |
dc.contributor.wosstandard | WOS:Rodriguez-Gallego, C | |
dc.contributor.wosstandard | WOS:Lara, PC | |
dc.date.coverdate | Febrero 2014 | |
dc.identifier.ulpgc | Sí | es |
dc.description.sjr | 1,099 | |
dc.description.jcr | 2,914 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.author.dept | GIR IUIBS: Medio Ambiente y Salud | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.orcid | 0000-0003-3237-0316 | - |
crisitem.author.orcid | 0000-0002-4344-8644 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Henríquez Hernández, Luis Alberto | - |
crisitem.author.fullName | Bordón Rodríguez, Elisa de los Reyes | - |
crisitem.author.fullName | Rodríguez Gallego, José Carlos | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.